agilon health Inc (AGL)
The Gross Law Firm Notifies agilon health, inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AGL
The Gross Law Firm Notifies agilon health, inc. Investors of a Class Action Lawsuit and Upcoming Deadline - AGL
Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference January 21-22, 2026
Propanc Biopharma Explains How PRP Could Impact Pancreatic Cancer
HCA Healthcare - HCA Healthcare Names Erica Rossitto as Chief Nurse Executive
GT Biopharma Announces IND Submission for GTB-5550TriKE®, a B7-H3-targeted natural killer (NK) cell engager for B7-H3 expressing solid tumor cancers
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
Neurocrine Biosciences Presents Head-to-Head INGREZZA® (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR
Hoth Therapeutics Notification (HOTH)
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents
Cognex Corporation - Cognex Announces Fourth Quarter 2025 Earnings Release and Conference Call Dates